{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T20:51:17Z","timestamp":1787950277327,"version":"build-2784847793"},"reference-count":24,"publisher":"FapUNIFESP (SciELO)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Gastroenterol."],"published-print":{"date-parts":[[2014,12]]},"abstract":"<jats:p>Background Perianal fistulizing Crohn\u2019s disease is one of the most severe phenotypes of inflammatory bowel diseases. Combined therapy with seton placement and anti-TNF therapy is the most common strategy for this condition Objectives The aim of this study was to analyze the rates of complete perianal remission after combined therapy for perianal fistulizing Crohn\u2019s disease. Methods This was a retrospective observational study with perianal fistulizing Crohn\u2019s disease patients submitted to combined therapy from four inflammatory bowel diseases referral centers. We analyzed patients\u2019 demographic characteristics, Montreal classification, concomitant medication, classification of the fistulae, occurrence of perianal complete remission and recurrence after remission. Complete perianal remission was defined as absence of drainage from the fistulae associated with seton removal. Discussion A total of 78 patients were included, 44 (55.8%) females with a mean age of 33.8 (\u00b115) years. Most patients were treated with Infliximab, 66.2%, than with Adalimumab, 33.8%. Complex fistulae were found in 52\/78 patients (66.7%). After a medium follow-up of 48.2 months, 41\/78 patients (52.6%) had complete perianal remission (95% CI: 43.5%-63.6%). Recurrence occurred in four (9.8%) patients (95% CI: 0.7%-18.8%) in an average period of 74.8 months. Conclusions Combined therapy lead to favorable and durable results in perianal fistulizing Crohn\u2019s disease.<\/jats:p>","DOI":"10.1590\/s0004-28032014000400004","type":"journal-article","created":{"date-parts":[[2015,1,10]],"date-time":"2015-01-10T19:18:07Z","timestamp":1420917487000},"page":"284-289","source":"Crossref","is-referenced-by-count":39,"title":["PERIANAL COMPLETE REMISSION WITH COMBINED THERAPY (SETON PLACEMENT AND ANTI-TNF AGENTS) IN Crohn\u2019s DISEASE: a Brazilian multicenter observational study"],"prefix":"10.1590","volume":"51","author":[{"given":"Paulo Gustavo","family":"KOTZE","sequence":"first","affiliation":[{"name":"Universidade Cat\u00f3lica do Paran\u00e1 - PUCPR, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idblan Carvalho de","family":"ALBUQUERQUE","sequence":"additional","affiliation":[{"name":"Hospital Heli\u00f3polis, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 da Luz","family":"MOREIRA","sequence":"additional","affiliation":[{"name":"Universidade do Estado do Rio de Janeiro - UERJ, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanessa Bertrami","family":"TONINI","sequence":"additional","affiliation":[{"name":"Universidade Cat\u00f3lica do Paran\u00e1 - PUCPR, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia","family":"OLANDOSKI","sequence":"additional","affiliation":[{"name":"Universidade Cat\u00f3lica do Paran\u00e1 - PUCPR, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio Saddy Rodrigues","family":"COY","sequence":"additional","affiliation":[{"name":"Universidade de Campinas - UNICAMP, Brasil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.gastro.2003.08.025","article-title":"AGA technical review on perianal Crohn\u2019s disease","volume":"125","year":"2003","journal-title":"Gastroenterology"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1463-1318.2012.03124.x","article-title":"Combined modality treatment for complex fistulating perianal Crohn\u2019s disease","volume":"15","author":"Antakia R","year":"2013","journal-title":"Colorectal Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.dld.2007.07.155","article-title":"Imaging of perianal Crohn\u2019s disease","volume":"39","author":"Ardizzone S","year":"2007","journal-title":"Dig Liver Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0016-5085(80)90155-9","article-title":"Healing of perianal Crohn\u2019s disease with metronidazole","volume":"79","author":"Bernstein LH","year":"1980","journal-title":"Gastroenterology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/gut.2008.159251","article-title":"Adalimumab for the treatment of fistulas in patients with Crohn\u2019s disease","volume":"58","author":"Colombel JF","year":"2009","journal-title":"Gut"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/gutjnl-2013-304488","article-title":"Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn\u2019s disease: a randomised, double-blind, placebo controlled trial (ADAFI)","volume":"63","author":"Dewint P","year":"2014","journal-title":"Gut"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/j.1463-1318.2012.02944.x","article-title":"Biological immunomodulators improve the healing rate in surgically treated perianal Crohn\u2019s fistulas","volume":"14","author":"El-Gazzaz G","year":"2012","journal-title":"Colorectal Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1007\/s10350-007-9077-3","article-title":"Does infliximab infusions impact results of operative treatment for Crohn\u2019s perianal fistulas?","volume":"50","author":"Gaertner WB","year":"2007","journal-title":"Dis Colon Rectum"},{"issue":"12","key":"ref9","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1007\/s10350-006-0656-5","article-title":"Fistulating anal Crohn\u2019s disease: results of combined surgical and infliximab treatment","volume":"49","author":"Hyder SA","year":"2006","journal-title":"Dis Colon Rectum"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.dld.2007.07.154","article-title":"The natural history of perianal Crohn\u2019s disease","volume":"39","author":"Ingle SB","year":"2007","journal-title":"Dig Liver Dis"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/SLA.0b013e3181e61df5","article-title":"Trends in Surgery for Crohn\u2019s Disease in the Era of Infliximab","volume":"25","author":"Jones DW","year":"2010","journal-title":"Annals of Surgery"},{"key":"ref12","first-page":"163","article-title":"Perianal Crohn\u2019s disease","volume":"9","author":"Khaikin M","year":"2007","journal-title":"Isr Med Assoc J"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1038\/ajg.2009.509","article-title":"Prospective evaluation of anti-tumor necrosis factor therapy guided by magnetic resonance imaging for Crohn\u2019s perineal fistulas","volume":"104","author":"Ng SC","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"132","DOI":"10.7326\/0003-4819-123-2-199507150-00009","article-title":"Azathioprine and 6-mercaptopurine in Crohn\u2019s disease: a meta analysis","volume":"123","author":"Pearson DC","year":"1995","journal-title":"Ann Intern Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJM198005013021801","article-title":"Treatment of Crohn\u2019s disease with mercaptopurine: a long-term, randomized, double-blind study","volume":"302","author":"Present DH","year":"1980","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1056\/NEJM199905063401804","article-title":"Infliximab for the treatment of fistulas in patients with Crohn\u2019s disease","volume":"340","author":"Present DH","year":"1999","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/00054725-200303000-00003","article-title":"Treatment of perianal fistulizing Crohn\u2019s disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement","volume":"9","author":"Regueiro M","year":"2003","journal-title":"Inflamm Bowel Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.3748\/wjg.v17.i15.1939","article-title":"Perianal Crohn\u2019s disease: is there something new?","volume":"17","author":"Ruffolo C","year":"2011","journal-title":"World J Gastroenterol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJMoa030815","article-title":"Infliximab Maintenance Therapy for Fistulizing","volume":"350","author":"Sands BE","year":"2004","journal-title":"N Engl J Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1463-1318.2004.00749.x","article-title":"Infliximab in the surgical management of complex fistulating anal\u00a0Crohn\u2019s disease","volume":"7","author":"Talbot C","year":"2005","journal-title":"Colorectal Dis"},{"key":"ref21","first-page":"144","article-title":"Long-term treatment of perianal or fistulous Crohn\u2019s disease with ciprofloxacin","volume":"24","author":"Turunen U","year":"1989","journal-title":"Scand J Gastroenterol Suppl"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.crohns.2009.09.009","article-title":"The second European evidence-based Consensus on the diagnosis and management of Crohn\u2019s disease: Special situations","volume":"4","author":"Van Assche G","year":"2010","journal-title":"J Crohns Colitis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0002-9270(02)05909-9","article-title":"Magnetic resonance imaging of the effects of infliximab on perianal fistulating Crohn\u2019s disease","volume":"98","author":"Van Assche G","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.dld.2007.07.153","article-title":"Perianal Crohn\u2019s disease: classification and clinical evaluation","volume":"39","author":"Vermeire S","year":"2007","journal-title":"Dig Liver Dis"}],"container-title":["Arquivos de Gastroenterologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/ag\/v51n4\/0004-2803-ag-51-04-283.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T14:31:15Z","timestamp":1566225075000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-28032014000400284&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0004-28032014000400284"],"URL":"https:\/\/doi.org\/10.1590\/s0004-28032014000400004","relation":{},"ISSN":["0004-2803"],"issn-type":[{"value":"0004-2803","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]}}}